Literature DB >> 16753325

Ornithine deficiency in the arginase double knockout mouse.

Joshua L Deignan1, Justin C Livesay, Paul K Yoo, Stephen I Goodman, William E O'Brien, Ramaswamy K Iyer, Stephen D Cederbaum, Wayne W Grody.   

Abstract

Knockout mouse models have been created to study the consequences of deficiencies in arginase AI and AII, both individually and combined. The AI knockout animals die by 14 days of age from hyperammonemia, while the AII knockout has no obvious phenotype. The double knockout (AI(-/-)/AII(-/-)) exhibits the phenotype of the AI-deficient mice, with the additional absence of AII not exacerbating the observed phenotype of the AI knockout animals. Plasma amino acid measurements in the double knockout have shown arginine levels increased roughly 100-fold and ornithine decreased roughly 10-fold as compared to wildtype. Liver ornithine levels were reduced to 2% of normal in the double knockout with arginine very highly elevated. Arginine and ornithine were also altered in other tissues in the double knockout mice, such as kidney, brain, and small intestine. This is the first demonstration that the fatal hyperammonemia in the AI knockout mouse is almost certainly due to ornithine deficiency, the amino acid needed to drive the urea cycle. Others have shown that the expression of ornithine aminotransferase (OAT) rapidly decreases in the intestine at the same age when the AI-deficient animals die, indicating that this enzyme is critical to the maintenance of ornithine homeostasis, at least at this early stage of mouse development. Although most human AI-deficient patients have no symptomatic hyperammonemia at birth, it is possible that clinically significant ornithine deficiency is already present.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16753325     DOI: 10.1016/j.ymgme.2006.04.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  27 in total

1.  Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine.

Authors:  Shunxing Rong; Jeffrey G McDonald; Luke J Engelking
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

2.  Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Authors:  Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander D Verin; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 3.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 4.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

Review 5.  Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

Authors:  Patrick Raber; Augusto C Ochoa; Paulo C Rodríguez
Journal:  Immunol Invest       Date:  2012       Impact factor: 3.657

6.  Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation.

Authors:  F M Menzies; F L Henriquez; J Alexander; C W Roberts
Journal:  Clin Exp Immunol       Date:  2010-01-05       Impact factor: 4.330

7.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

Review 8.  Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

Authors:  Paulo C Rodríguez; Augusto C Ochoa
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

9.  L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori.

Authors:  Rupesh Chaturvedi; Mohammad Asim; Nuruddeen D Lewis; Holly M Scott Algood; Timothy L Cover; Preston Y Kim; Keith T Wilson
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 10.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.